Cargando…

Multiple Myeloma Emerging after Prolonged Gefitinib Treatment for Non-Small Cell Lung Carcinoma

The coexistence of lung cancer and multiple myeloma (MM) is rare. A search of the English literature revealed only 5 case reports to date. We describe a case of MM that presented in a 78-year-old lung cancer patient after 20 months of treatment with gefitinib, an epidermal growth factor receptor tyr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sian Yik, Ando, Sachiko, Nishiyama, Kaoru, Padival, Simi
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080785/
https://www.ncbi.nlm.nih.gov/pubmed/21516269
http://dx.doi.org/10.1159/000327689
_version_ 1782202136728174592
author Lim, Sian Yik
Ando, Sachiko
Nishiyama, Kaoru
Padival, Simi
author_facet Lim, Sian Yik
Ando, Sachiko
Nishiyama, Kaoru
Padival, Simi
author_sort Lim, Sian Yik
collection PubMed
description The coexistence of lung cancer and multiple myeloma (MM) is rare. A search of the English literature revealed only 5 case reports to date. We describe a case of MM that presented in a 78-year-old lung cancer patient after 20 months of treatment with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor. We also review previously reported cases of concurrent development of lung cancer and MM.
format Text
id pubmed-3080785
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-30807852011-04-22 Multiple Myeloma Emerging after Prolonged Gefitinib Treatment for Non-Small Cell Lung Carcinoma Lim, Sian Yik Ando, Sachiko Nishiyama, Kaoru Padival, Simi Case Rep Oncol Published online: April 2011 The coexistence of lung cancer and multiple myeloma (MM) is rare. A search of the English literature revealed only 5 case reports to date. We describe a case of MM that presented in a 78-year-old lung cancer patient after 20 months of treatment with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor. We also review previously reported cases of concurrent development of lung cancer and MM. S. Karger AG 2011-04-06 /pmc/articles/PMC3080785/ /pubmed/21516269 http://dx.doi.org/10.1159/000327689 Text en Copyright © 2011 S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published online: April 2011
Lim, Sian Yik
Ando, Sachiko
Nishiyama, Kaoru
Padival, Simi
Multiple Myeloma Emerging after Prolonged Gefitinib Treatment for Non-Small Cell Lung Carcinoma
title Multiple Myeloma Emerging after Prolonged Gefitinib Treatment for Non-Small Cell Lung Carcinoma
title_full Multiple Myeloma Emerging after Prolonged Gefitinib Treatment for Non-Small Cell Lung Carcinoma
title_fullStr Multiple Myeloma Emerging after Prolonged Gefitinib Treatment for Non-Small Cell Lung Carcinoma
title_full_unstemmed Multiple Myeloma Emerging after Prolonged Gefitinib Treatment for Non-Small Cell Lung Carcinoma
title_short Multiple Myeloma Emerging after Prolonged Gefitinib Treatment for Non-Small Cell Lung Carcinoma
title_sort multiple myeloma emerging after prolonged gefitinib treatment for non-small cell lung carcinoma
topic Published online: April 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080785/
https://www.ncbi.nlm.nih.gov/pubmed/21516269
http://dx.doi.org/10.1159/000327689
work_keys_str_mv AT limsianyik multiplemyelomaemergingafterprolongedgefitinibtreatmentfornonsmallcelllungcarcinoma
AT andosachiko multiplemyelomaemergingafterprolongedgefitinibtreatmentfornonsmallcelllungcarcinoma
AT nishiyamakaoru multiplemyelomaemergingafterprolongedgefitinibtreatmentfornonsmallcelllungcarcinoma
AT padivalsimi multiplemyelomaemergingafterprolongedgefitinibtreatmentfornonsmallcelllungcarcinoma